Audit of a series of 40 gastrointestinal stromal tumour cases
- 31 December 2006
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (10) , 1125-1129
- https://doi.org/10.1016/j.ejso.2006.05.018
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutantsGastroenterology, 2005
- Gastrointestinal Stromal Tumors of the StomachThe American Journal of Surgical Pathology, 2005
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- KIT-Negative Gastrointestinal Stromal TumorsThe American Journal of Surgical Pathology, 2004
- Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal TumorsClinical Cancer Research, 2004
- Gastrointestinal stromal tumoursBritish Journal of Surgery, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Diagnosis of Gastrointestinal Stromal Tumors:A Consensus ApproachInternational Journal of Surgical Pathology, 2002
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyJournal of Clinical Oncology, 1999